Opportunities for improving how and when Canadians are informed about new prescription medications

Autor: Helen Monkman, Andre W. Kushniruk, Elizabeth M. Borycki, Debra Sheets, Jeff Barnett, Hannah Park

Publikováno v: Knowledge Management & E-Learning: An International Journal, Vol 12, Iss 4, Pp 427-447 (2020)

The Canadian prescription process requires a person to go through several steps. Prescription medications have associated risks and benefits and it is important for people to be aware of these before and while they are taking medications. One of the

Externí odkaz: https://doaj.org/article/f378e96b22434639875145cbbd6dd479

The Medium Is the Message: How Do Canadian University Students Want Digital Medication Information?

Autor: Christian Nøhr, Elizabeth M. Borycki, Helen Monkman, Debra Sheets, Andre Kushniruk, Jeff Barnett

Publikováno v: Life; Volume 10; Issue 12; Pages: 339
Life
Monkman, H, Kushniruk, A, Borycki, E, Sheets, D, Barnett, J & Nøhr, C 2020, ' The medium is the message : How do canadian university students want digital medication information? ', Life, vol. 10, no. 12, 339 . https://doi.org/10.3390/life10120339
Life, Vol 10, Iss 339, p 339 (2020)

(1) Background: To facilitate optimal prescription medication benefits and safety, it is important that people are informed about their prescription medications. As we shift towards using the digital medium to communicate medication information, it i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d09f14d336d62ee6b8259aadf6ca89

Deriving a Set of Privacy Specific Heuristics for the Assessment of PHRs (Personal Health Records)

Autor: Riccardo F, Furano, Andre, Kushniruk, Jeff, Barnett

Publikováno v: Studies in health technology and informatics. 234

With the emergence of personal health record (PHR) platforms becoming more widely available, this research focused on the development of privacy heuristics to assess PHRs regarding privacy. Existing sets of heuristics are typically not application sp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e6e9798ef429b78a605d9f6f46d1c409
https://pubmed.ncbi.nlm.nih.gov/28186028

Use of combined androgen blockade for advanced prostate cancer in British Columbia

Autor: Mário L de Lemos, Jeff Barnett, P. Blood, Tom Pickles, Laurel Kovacic, Shirin Abadi, Adeline Chau

Publikováno v: Journal of Oncology Pharmacy Practice. 16:121-126

Objectives. Initial androgen deprivation therapy (ADT) for metastatic prostate cancer with combined androgen blockade (luteinizing-hormone releasing hormone agonist [LHRH agonist] plus antiandrogen) is not recommended in British Columbia (BC). Howeve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc8afa74ccdf4c0664cd1cab22431e78
https://doi.org/10.1177/1078155209337661

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen

Autor: Chris Bajdik, Ivo A. Olivotto, Hagen Kennecke, Heather L. McArthur, B. Norris, Malcolm Hayes, Susan Ellard, Caroline Speers, Jeff Barnett, Karen A. Gelmon, Stephen Chia

Publikováno v: Cancer. 112:1437-1444

BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)-positive breast cancer. An understanding of which patients are at risk of early

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b28f714cabf7386562692c7b97cdcd0
https://doi.org/10.1002/cncr.23320